Drug
TM Buprenorphine
TM Buprenorphine: highest development phase Post-Market, developed by Indivior. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Indivior
Trials
| Drug | Phase | Indication |
|---|---|---|
| TM buprenorphine NCT03993392 | Post-Market | Opioid-use Disorder |
Latest
No recent events.
Follow TM Buprenorphine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.